Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study

Abstract Background Hemodialysis patients are among high-risk groups for COVID-19. Africa is the continent with the lowest number of cases in the general population but we have little information about the disease burden in dialysis patients. Objectives This study aimed to describe the seroprevalenc...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sidy Mohamed Seck, Moustapha Mbow, Yaya Kane, Mouhamadou Moustapha Cisse, Gnagna Faye, Adama Kama, Moussa Sarr, Pamela Nitcheu, Mohamed Dahaba, Ibrahima Mbemba Diallo, Mame Selly Diawara, Lotingo Nehemie Motoula Latou, Yacine Dia, Souleymane Mboup
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	SARS-CoV-2 COVID-19 Seroprevalence Hemodialysis Senegal Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/9f8c8dadb70148b4a893b7be4b1e684b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study

Ejemplares similares